Articles

FEMY stock results show that Femasys beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. More

LABP stock results show that Landos Biopharma missed analyst estimates for earnings per share the first quarter of 2024. More

CVKD stock results show that Cadrenal Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. More

Saga Communications just reported results for the first quarter of 2024. More

DYNT stock results show that Dynatronics beat analyst estimates for earnings per share but missed on revenue for the third quarter of 2024. More

Discover three materials stocks to sell facing challenges in May 2024 due to market conditions, oversupply and rising costs. More

The stock market is constantly bombarded with hype. However, there are overlooked growth stocks that will emerge as winners through 2030. More

Subscriber Sign in